In a new post on PLOS Blogs, Tom Jefferson looks at what Europe’s medicines body’s new policy on releasing information from clinical trials might mean for journals and researchers who combine clinical trial information in systematic reviews. This is the policy that that hundreds of you wrote to the European Medicines Agency about. Jefferson, who has worked on a number of systematic reviews, thinks the new policy will “revolutionise publishing and produce better synthesis assessments”. Read the full article on PLOS Blogs.
